About Us
ACT-AD is a coalition of committed national organizations seeking to accelerate development of potential cures and treatments to slow, halt or reverse the progression of Alzheimer’s disease through research. Read More
Take Action
Join ACT-AD in making the acceleration and cure for Alzheimer’s disease a national priority. Read More
About the Issue
The impact that Alzheimer’s has on individuals, families and our health care system makes the disease one of our nation’s greatest medical, social and economic challenges. There are currently 4.5 million Americans diagnosed with Alzheimer’s and by 2050 the number is expected to grow to an estimated 14 million. Read More
ACT-AD Activities
ACT-AD and our members conduct activities throughout the year to focus attention on the need to accelerate cures and treatments for Alzheimer's disease.
Latest News
| Alzheimer's / Dementia News From Medical News Today | |
| Age Concern And Help The Aged Comment On Dementia Research, UK Thursday, February 04, 2010 |
|
| Dementia Costs UK More Than Cancer But Gets Less Research Funding, Report Wednesday, February 03, 2010 |
|
| Cigarette Smoking A Risk For Alzheimer's Disease According To Study Tuesday, February 02, 2010 |
|
| ScienceDaily: Alzheimer's Research News | |
| Marijuana ineffective as an Alzheimer's treatment Tuesday, February 09, 2010 |
|
| Mediterranean diet may lower risk of brain damage that causes thinking problems Tuesday, February 09, 2010 |
|
| Drug shows promise for Huntington's disease Tuesday, February 09, 2010 |
|
| CQ HealthBeat News | |
| Study: Many Latinos Lack Usual Health Care Provider Wednesday, August 13, 2008 |
|
| Survival Tactics By Safety Net Providers May Mean Less Free Care Tuesday, August 12, 2008 |
|
| Doggett Bill Would Remove Social Security Numbers from Medicare Cards Friday, August 08, 2008 |
|
We need your voice! The Act-AD Coalition's success depends upon the involvement of a diverse group of stakeholder organizations. Please join us in making the acceleration and cure for AD a national Priority.